» Articles » PMID: 33168762

Recurrent Thunderclap Headaches from Reversible Cerebral Vasoconstriction Syndrome Associated with Duloxetine, Xylometazoline and Rhinitis Medicamentosa

Overview
Journal CMAJ
Date 2020 Nov 10
PMID 33168762
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Clinical Characteristics of COVID-19-Related Reversible Cerebral Vasoconstriction Syndrome: A Systematic Review of Case Series.

Jung R, Oh Y, Choi S, Park M, Ha H, Kim N J Clin Med. 2025; 14(2).

PMID: 39860493 PMC: 11765861. DOI: 10.3390/jcm14020487.


The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptors.

Proudman R, Baker J Pharmacol Res Perspect. 2021; 9(4):e00799.

PMID: 34355529 PMC: 8343220. DOI: 10.1002/prp2.799.

References
1.
Kumar S, Goddeau Jr R, Selim M, Thomas A, Schlaug G, Alhazzani A . Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology. 2010; 74(11):893-9. PMC: 2836868. DOI: 10.1212/WNL.0b013e3181d55efa. View

2.
de Boysson H, Parienti J, Mawet J, Arquizan C, Boulouis G, Burcin C . Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome: A comparative study. Neurology. 2018; 91(16):e1468-e1478. DOI: 10.1212/WNL.0000000000006367. View

3.
Cappelen-Smith C, Calic Z, Cordato D . Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment. Curr Treat Options Neurol. 2017; 19(6):21. DOI: 10.1007/s11940-017-0460-7. View

4.
Loch Macdonald R, Schweizer T . Spontaneous subarachnoid haemorrhage. Lancet. 2016; 389(10069):655-666. DOI: 10.1016/S0140-6736(16)30668-7. View

5.
Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser M . The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007; 130(Pt 12):3091-101. DOI: 10.1093/brain/awm256. View